Table 2.
Virus‐related pathway enriched by target genes
| ID | Description | Gene ratio | P‐value | P‐adjust | q‐value | Count |
|---|---|---|---|---|---|---|
| hsa05161 | Hepatitis B | 22/63 | 2.84E‐22 | 1.19E‐20 | 2.92E‐21 | 22 |
| hsa05167 | Kaposi sarcoma‐associated herpesvirus infection | 22/63 | 1.47E‐20 | 3.24E‐19 | 7.98E‐20 | 22 |
| hsa05160 | Hepatitis C | 20/63 | 1.18E‐19 | 2.16E‐18 | 5.33E‐19 | 20 |
| hsa05163 | Human cytomegalovirus infection | 22/63 | 4.39E‐19 | 6.79E‐18 | 1.67E‐18 | 22 |
| hsa05170 | Human immunodeficiency virus 1 infection | 21/63 | 2.54E‐18 | 3.20E‐17 | 7.87E‐18 | 21 |
| hsa05164 | Influenza A | 19/63 | 1.59E‐17 | 1.89E‐16 | 4.64E‐17 | 19 |
| hsa05169 | Epstein‐Barr virus infection | 16/63 | 1.73E‐12 | 8.08E‐12 | 1.99E‐12 | 16 |
| hsa05165 | Human papillomavirus infection | 18/63 | 3.33E‐11 | 1.29E‐10 | 3.17E‐11 | 18 |
| hsa05166 | Human T‐cell leukaemia virus 1 infection | 14/63 | 9.05E‐10 | 3.03E‐09 | 7.46E‐10 | 14 |
| hsa05203 | Viral carcinogenesis | 9/63 | 2.58E‐05 | 5.29E‐05 | 1.30E‐05 | 9 |
| hsa04061 | Viral protein interaction with cytokine and cytokine receptor | 5/63 | .001056 | .001768 | 0.000435 | 5 |
| hsa05416 | Viral myocarditis | 3/63 | .011338 | .016395 | 0.004035 | 3 |